Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$155.22 - $162.74 $48,273 - $50,612
311 Added 12.16%
2,869 $453,000
Q4 2023

Jan 30, 2024

BUY
$145.6 - $158.88 $5,969 - $6,514
41 Added 1.63%
2,558 $400,000
Q3 2023

Oct 26, 2023

BUY
$155.75 - $174.48 $15,730 - $17,622
101 Added 4.18%
2,517 $392,000
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $80,725 - $86,875
523 Added 27.63%
2,416 $399,000
Q1 2023

Apr 26, 2023

SELL
$151.05 - $180.26 $11,026 - $13,158
-73 Reduced 3.71%
1,893 $293,000
Q4 2022

Jan 20, 2023

BUY
$160.2 - $179.79 $14,097 - $15,821
88 Added 4.69%
1,966 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $13,229 - $14,720
82 Added 4.57%
1,878 $307,000
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $5,886 - $6,510
-35 Reduced 1.91%
1,796 $319,000
Q1 2022

Apr 26, 2022

SELL
$158.14 - $179.59 $70,846 - $80,456
-448 Reduced 19.66%
1,831 $325,000
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $62,839 - $69,723
-403 Reduced 15.03%
2,279 $390,000
Q3 2021

Oct 14, 2021

BUY
$161.5 - $179.47 $36,337 - $40,380
225 Added 9.16%
2,682 $433,000
Q2 2021

Jul 13, 2021

BUY
$159.48 - $171.07 $69,692 - $74,757
437 Added 21.63%
2,457 $405,000
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $68,881 - $76,716
450 Added 28.66%
2,020 $332,000
Q4 2020

Jan 26, 2021

SELL
$137.11 - $157.38 $17,001 - $19,515
-124 Reduced 7.32%
1,570 $247,000
Q3 2020

Oct 07, 2020

SELL
$140.38 - $153.83 $1,965 - $2,153
-14 Reduced 0.82%
1,694 $252,000
Q2 2020

Jul 07, 2020

SELL
$128.81 - $155.51 $71,618 - $86,463
-556 Reduced 24.56%
1,708 $244,000
Q1 2020

Apr 08, 2020

SELL
$111.14 - $153.99 $41,899 - $58,054
-377 Reduced 14.27%
2,264 $297,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $336,727 - $386,748
2,641 New
2,641 $385,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Beam Wealth Advisors, Inc. Portfolio

Follow Beam Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beam Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beam Wealth Advisors, Inc. with notifications on news.